Giles, F. J., Abruzzese, E., Rosti, G., Kim, D., Bhatia, R., Bosly, A., . . . Kantarjian, H. M. (2010). Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy.
Citação norma ChicagoGiles, Francis J., et al. Nilotinib Is Active in Chronic and Accelerated Phase Chronic Myeloid Leukemia Following Failure of Imatinib and Dasatinib Therapy. 2010.
MLA CitationGiles, Francis J., et al. Nilotinib Is Active in Chronic and Accelerated Phase Chronic Myeloid Leukemia Following Failure of Imatinib and Dasatinib Therapy. 2010.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.